| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/23/2009 | CA2163456C New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 06/18/2009 | WO2009076455A2 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents |
| 06/18/2009 | WO2009076212A1 Catalytic topoisomerase ii inhibitors |
| 06/18/2009 | WO2009076195A1 Treatment of drug-induced nausea with opioid antagonists |
| 06/18/2009 | WO2009076170A2 Combinations of therapeutic agents for treating cancer |
| 06/18/2009 | WO2009075841A2 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 06/18/2009 | WO2009075838A2 Treatment of menorrhagia with aromatase inhibitor |
| 06/18/2009 | WO2009075344A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof |
| 06/18/2009 | WO2009075334A1 Uterine fibroid cell growth inhibitor, and prophylactic or therapeutic agent for uterine fibroid comprising the inhibitor |
| 06/18/2009 | WO2009075084A1 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease |
| 06/18/2009 | WO2009074969A2 Spingosine-1-phosphate, analogues and antagonists for use as medicaments |
| 06/18/2009 | WO2009074835A1 Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity |
| 06/18/2009 | WO2009074827A2 Combination comprising a mek inhibitor and an aurora kinase inhibitor |
| 06/18/2009 | WO2009074794A2 Anti-inflammatory compositions and combinations |
| 06/18/2009 | WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009073911A1 Treatment and prophylaxis |
| 06/18/2009 | WO2009043170A8 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 06/18/2009 | WO2007144679A3 Compounds, kits and methods for conferring cytoprotection |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090156688 Suppressant of toxicity induced by cancer chemotherapeutic agent and composition of cancer chemotherapeutic agent containing the same |
| 06/18/2009 | US20090156639 Compositions and methods of treatment using l-type calcium channel blockers and cholinesterase inhibitors |
| 06/18/2009 | US20090156549 Mucosal treatment |
| 06/18/2009 | US20090156527 Antiviral oligonucleotides targeting viral families |
| 06/18/2009 | US20090156463 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 06/18/2009 | US20090156458 Assay for the detection of factors that modulate the expression of inagp |
| 06/18/2009 | US20090156413 Method, system, apparatus and device for discovering and preparing chemical compounds for medical and other uses |
| 06/18/2009 | US20090155789 Genes from the 20q13 amplicon and their uses |
| 06/18/2009 | US20090155324 Skin Treatment System |
| 06/18/2009 | US20090155313 Vaccine Against Salmonid Rickettsial Septicaemia Based on Arthrobacter Cells |
| 06/18/2009 | US20090155273 Remedies for inflammatory bowel diseases |
| 06/18/2009 | US20090155265 Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies |
| 06/18/2009 | US20090155264 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | US20090155263 Compositions and methods for the treatment of immune related diseases |
| 06/18/2009 | US20090155240 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 06/18/2009 | US20090155229 Chondrocyte-based implant for the delivery of therapeutic agents |
| 06/18/2009 | US20090155223 Cell-based compositions and methods for treating conditions of the nervous system |
| 06/18/2009 | US20090155218 Compositions and methods for growth of embryonic stem cells |
| 06/18/2009 | US20090155216 Grafting Material and Agent for Improvement in bone Quality |
| 06/18/2009 | US20090155213 Lactobacillus acidophilus nucleic acids and uses thereof |
| 06/18/2009 | US20090155212 Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| 06/18/2009 | US20090155211 Methods and Compositions for the Treatment of Autoimmune Disorders Using Clofarabine |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/18/2009 | US20090155185 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 06/18/2009 | US20090155178 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/18/2009 | US20090155174 RNA Interference Mediating Small RNA Molecules |
| 06/18/2009 | DE202009003549U1 Variabel und präzise dosierbare feste Arzneiform enthaltend ein Antiepileptikum Variable and precisely metered solid dosage form comprising an antiepileptic drug |
| 06/18/2009 | CA2708606A1 Methods of treating hematologic cancers |
| 06/18/2009 | CA2708352A1 Anti-inflammatory compositions and combinations |
| 06/18/2009 | CA2708264A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 06/18/2009 | CA2708149A1 Combinations of therapeutic agents for treating cancer |
| 06/17/2009 | EP2071481A2 Method system, apparatus and device for discovering and preparing chemical compounds for medical and other uses |
| 06/17/2009 | EP2071040A2 Diagnostics and therapeutics for vascular disease |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP2070939A1 Modulators of pharmacological agents |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070550A1 Use of combinations comprising a corticosteroid and a pyrimidopyrimidine in the treatment of inflammatory diseases |
| 06/17/2009 | EP2070549A1 Therapeutic agent for acceleration of spinal nerve repair comprising desacyl ghrelin or derivative thereof as active ingredient |
| 06/17/2009 | EP2070546A1 Preventives/remedies for cancer |
| 06/17/2009 | EP2070540A1 Drug composition for treating 2 type diabetes and its chronicity neopathy |
| 06/17/2009 | EP2070536A1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 06/17/2009 | EP2070530A1 Treatment of diseases associated with the use of antibiotics |
| 06/17/2009 | EP2070526A1 "Methods for treatment of Parkinson's disease" |
| 06/17/2009 | EP2070519A1 Preparation for the prevention and/or treatment of dementia syndromes |
| 06/17/2009 | EP2070513A1 Antioxidant combinations with 6,7 disubstituted 2.2-dialkylchromanes or chromenes |
| 06/17/2009 | EP2069377A2 Methods and compositions for the treatment of skin diseases and disorders |
| 06/17/2009 | EP2068932A2 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 06/17/2009 | EP2068931A1 Treatment of fibrosis |
| 06/17/2009 | EP2068891A2 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 06/17/2009 | EP2068884A2 Hydroxycholesterols and its prodrugs for the treatment of insulin resistance and disorders associated therewith |
| 06/17/2009 | EP2068872A1 Combinations containing a 4-acylaminopyridine derivative |
| 06/17/2009 | EP2068861A2 Compositions comprising omega-3 fatty acids, and their use in treating peripheral artery disease and intermittent claudication |
| 06/17/2009 | EP1791423A4 Compositions and methods for the management of hyperproliferative dermatological conditions |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1439839B1 A combination comprising combretastatin and anticancer agents |
| 06/17/2009 | EP1390378B1 Pharmaceutically active uridine esters |
| 06/17/2009 | CN101460197A Combination of organic compounds |
| 06/17/2009 | CN101460196A Progastrin inhibitors in the treatment of colon cancer |
| 06/17/2009 | CN101455842A Medicine composition of HMG-CoA reductase inhibitor and probucol |
| 06/17/2009 | CN100500658C Pharmaceutical composition of male sexual dysfunction |
| 06/17/2009 | CN100500220C Anti entity tumour medicinal composition containing blood vessel inhibitor |
| 06/17/2009 | CN100500219C Anti tumour medicinal composition containing platinum compound |
| 06/17/2009 | CN100500218C Anti tumour medicinal composition |
| 06/17/2009 | CN100500217C Anti tumour medicinal composition |
| 06/17/2009 | CN100500216C Anti entity tumour medicinal composition containing dichloro ethamine kind drug |
| 06/17/2009 | CN100500215C Slow-released injection containing methotrexate and its synergist |
| 06/17/2009 | CN100500214C Slow-released anticancer medicine injection |
| 06/17/2009 | CN100500213C Anti-tumour medicinal composition containing blood vessel inhibitor |
| 06/17/2009 | CN100500212C Anti entity tumour medicinal composition |
| 06/17/2009 | CN100500210C Use of il-18 inhibitors in hypersensitivity disorders |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547719 Thrombopoietin mimetic; useful as an agonist of the TPO receptor, particularly in enhancing platelet production; treatment of thrombocytopenia |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/16/2009 | US7547711 Heterocyclic inhibitors of kinases |
| 06/16/2009 | US7547544 Hybridoma cell line for production of immunoglobulins specific to g protein coupled receptor for use in prevention and treatment of cell proliferative disorders |
| 06/16/2009 | US7547543 Retinoid-Related Orphan Receptor (ROR) receptor response element ; drug screening |
| 06/16/2009 | US7547532 Three-dimensional structure of prostaglandin D synthase and utilization thereof |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | US7547441 PAI-2 conjugates for the treatment and imaging of cancer |
| 06/16/2009 | CA2591758C Applicator for the delivery of topical formulation into mucosal cavities |